Welcome to Novo Nordisk Rare Diseases Science Hub
The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.
The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.
Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.
By accessing this website you accept this legal notice and expressly confirm your status as a non-US healthcare professional.
Christoph Königs is based at the Pediatric Hemophilia Center, University Hospital Frankfurt, Germany since 2002. He has received his degree in science from Monash University, Melbourne, Australia in 1998 and his medical degree from Goethe University Frankfurt, Germany in 2002. For both, his MD and PhD thesis Christoph isolated ligands to clinically relevant structures of protein receptors and RNA.
The main clinical and scientific interest of his research team is the understanding and modification of the immune response to coagulations factors. The main clinical focus has been developing and improving therapies for children and adolescents with coagulation disorders with a focus on patient education and shared decision making.
Christoph has specialized in Pediatrics and Adolescent Medicine and also in Hemostasis. He is a member of several national and international scientific societies and committees. He co-chairs the “Standing Committee Hemophilia” of the Society for Thrombosis and Hemostasis (GTH), the national registry on PUPs with newly diagnosed hemophilias in Germany “GEPHARD” and the scientific advisory council of PedNet. Christoph is closely working together with the German patient organizations i.e. as a deputy chair of the medical advisory board.
